Cleared Traditional

K180247 - DAEHAN Adhesive Surface Electrodes

K180247 is the FDA 510(k) clearance for DAEHAN Adhesive Surface Electrodes by Daehan Medical Systems Co., Ltd.. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 276-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
276d
Days
Class 2
Risk

K180247 is an FDA 510(k) clearance for the DAEHAN Adhesive Surface Electrodes. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Daehan Medical Systems Co., Ltd. (Siheung-City, KR). The FDA issued a Cleared decision on November 1, 2018 after a review of 276 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Daehan Medical Systems Co., Ltd. devices

Submission Details

510(k) Number K180247 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 2018
Decision Date November 01, 2018
Days to Decision 276 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
128d slower than avg
Panel avg: 148d · This submission: 276d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 141
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K180247.
SM Electrodes
K183154 · Hong Qiangxing (Shenzhen) Electronics Limited · Mar 2019
DL Self-adhesive Electrode
K182111 · Shaoxing DL Healthcare Co., Ltd. · Jan 2019
Espire Elbow Pro, Espire Elbow Hybrid
K182757 · College Park Industries, Inc. · Nov 2018
Sense System with IBT Electrodes
K182112 · Infinite Biomedical Technologies, LLC · Oct 2018
Self-adhesive Electrode
K181234 · Dong Guan OU Kang Electronics Co., Ltd. · Aug 2018
ZMI Self-Adhesive Electrodes
K180865 · Zmi Electronics , Ltd. · Jun 2018